I spoke to board-certified dermatologists about how to shop for exfoliating products based on your skin type and craft a proper skin care routine for your face and body. I also compiled expert ...

Japanese drugmaker Eisai (TYO: 4523) said yesterday that it has received a favorable decision regarding the lawsuit filed in ...

Shilpa Medicare failed to prove invalidity of patent covering Lenvima | Eisai says ruling keeps India-based generic maker’s ...

The verdict of the US district court in New Jersey is that Shilpa's generic infringes a US patent on multikinase inhibitor ...

Eisai Co., Ltd. engages in the development, manufacture, and sale of prescription medicines and over-the-counter products. It operates through the Pharmaceutical Products Business and Other ...

Japanese drugmaker Eisai (TYO: 4523) today announced that the in-house-discovered and developed orexin receptor antagonist ...

The fourth round of job cuts this year at global drugmaker Eisai‘s U.S. corporate headquarters will take effect on May 30. The oncology and neurology pharmaceutical company from Japan announced ...

Eisai announced today the presentation of clinical research across its oncology portfolio and pipeline during the 2025 ...

"At Eisai, our pursuit of scientific advancement ... investigational compounds and investigational uses for FDA-approved products. It is not intended to convey conclusions about efficacy and ...

Available in 16 colors and 16-foot lengths, LP’s trim and siding come in a “brushed smooth” texture, offering both a durable product and a smooth, modern look. GAF’s latest iteration of ...